SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke

Completed

Conditions studied: Occlusive Stroke

In brief

The objective of this study is to obtain post market data on the Asahi Chikai Black 18 neurovascular guidewire in the treatment of intracranial large vessel occlusive stroke. This will be compared to a historical control that will include the prior 50 consecutive patients fitting the same selection criteria.

Key facts

Study ID

NCT03438565

Run by

Icahn School of Medicine at Mount Sinai

People needed

100

Starts

2018-03-18

Expected to finish

2020-02-01

Last updated by the study team

2020-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients presenting with acute anterior cerebral circulation large vessel occlusive stroke
• ASPECT score 5 or better
• Occlusion of the ICA terminus and M1 MCA
• Favorable CT perfusion with clinical/radiologic mismatch
• Last known well out to 24 hours
• Age limit >18 years
• Baseline mRS 0-3

You may not qualify if…

• Intracranial hemorrhage
• ASPECTS (Alberta stroke program early CT score) <5
• Unfavorable CT perfusion
• Baseline mRS 4 or greater
• Large vessel occlusive stroke with tandem lesion of the cervical internal carotid artery or posterior circulation

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.